These highlights do not include all the information needed to use POTIGA safely and effectively. See full prescribing information for POTIGA.
POTIGA (ezogabine) tablets, for oral use, CV
Initial U.S. Approval: 2011
WARNING: RETINAL ABNORMALITIES AND POTENTIAL VISION LOSS
See full prescribing information for complete boxed warning.
-
•
-
POTIGA can cause retinal abnormalities with funduscopic features similar to those seen in retinal pigment dystrophies, which are known to result in damage to the photoreceptors and vision loss. (5.1)
